Wang On Group Limited provided consolidated earnings guidance for the six months ended September 30, 2023. For the period, the company expected to record a turnaround from the loss attributable to owners of the parent for the six months ended 30 September 2022 of approximately HKD 23.6 million to a profit attributable to owners of the parent of not more than HKD 130.0 million for the six months ended 30 September 2023. This was primarily attributable to, among other things, (i) increase in share of result of joint ventures, and (ii) increase in sales and gross profit generated from the production and sale of pharmaceutical and health food products, as partially offset by (a) decrease in gross profit resulting from decrease in delivery of property projects and (b) increase in finance costs arising from interest rates increment during the Review Period as compared to those for the corresponding period in 2022.